Shield Therapeutics Plc (STX.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 12-2017 | 06-2017 | 12-2016 | 06-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,586 | 17,972 | 27,999 | 25,883 | 37,982 |
| Inventories | 197 | 169 | 180 | 516 | 328 |
| Other current assets | 1,642 | 715 | 2,737 | 1,305 | 1,578 |
| TOTAL | $6,426 | $20,266 | $30,916 | $28,848 | $39,888 |
| Non-Current Assets | |||||
| PPE Net | 13 | 18 | 21 | 23 | 31 |
| Intangibles | 41,197 | 40,489 | 38,861 | 35,761 | 36,743 |
| TOTAL | $41,210 | $40,507 | $38,882 | $35,784 | $36,774 |
| Total Assets | $47,636 | $60,773 | $69,798 | $64,632 | $76,661 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,556 | 2,435 | 3,427 | 1,838 | 3,975 |
| Other current liabilities | 254 | N/A | 256 | N/A | 242 |
| TOTAL | $3,810 | $5,085 | $3,683 | $4,920 | $4,217 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $3,810 | $5,085 | $3,683 | $4,920 | $4,217 |
| Shareholders' Equity | |||||
| Common Shares | 2,283 | 2,360 | 2,272 | 2,001 | 2,165 |
| Retained earnings | -111,067 | -104,419 | -88,045 | -76,965 | -75,229 |
| Other shareholders' equity | 37,118 | 38,366 | 36,959 | 38,484 | 41,444 |
| TOTAL | $43,826 | $55,687 | $66,115 | $59,711 | $72,445 |
| Total Liabilities And Equity | $47,636 | $60,773 | $69,798 | $64,632 | $76,661 |